Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers

Background: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). Materials and Methods: Patients diagnosed with AGC, receiving biweekly mFOLFIRI between July 2013 and June 2016, as second-line c...

Полное описание

Библиографические подробности

Главные авторы:	Anant Ramaswamy, Vikas Ostwal, Kushal Gupta, Vijai Simha, Anup Toshniwal, Nitin Shetty, Chaitali Nashikkar, Sarika Mandavkar, Sudeep Gupta
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Серии:	South Asian Journal of Cancer
Предметы:	Advanced gastric cancers modified 5-fluorouracil/leucovorin/irinotecan second-line chemotherapy
Online-ссылка:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2018;volume=7;issue=4;spage=219;epage=222;aulast=Ramaswamy
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!